These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 292806)
21. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer]. Paulick R; Caffier H Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751 [TBL] [Abstract][Full Text] [Related]
22. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage. Salvati F; Antilli A; Cruciani AR; Pau F; Flore F; Munno R; De Angelis G; Cipri A; Pigorini F Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030 [TBL] [Abstract][Full Text] [Related]
23. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer]. Pan QR; Zhang X; Xu ZF; Zheng S Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076 [TBL] [Abstract][Full Text] [Related]
24. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer. Staab HJ; Ahlemann LM; Koch HL; Anderer FA Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702 [TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen. Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106 [TBL] [Abstract][Full Text] [Related]
26. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women. Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791 [TBL] [Abstract][Full Text] [Related]
27. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer. Lamerz R; Leonhardt A; Ehrhart H; von Lieven H Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699 [TBL] [Abstract][Full Text] [Related]
28. [Ferritin, CEA and TPA as tumor markers in breast neoplasms]. Bonanni F; Folco U; Giudici Cipriani A; Buffa E; Amedeo A; Bertolotto M; Rembado R; Barbetti V; Guglieri F Minerva Med; 1985 Sep; 76(34-35):1533-4. PubMed ID: 4034052 [TBL] [Abstract][Full Text] [Related]
29. [CA 15-3 associated with CEA and TPA in the follow-up of breast carcinoma]. Maffei S; Rudoni M; Antonini G; Sacchetti G; Krengli M Minerva Med; 1990 Nov; 81(11):759-63. PubMed ID: 2255409 [TBL] [Abstract][Full Text] [Related]
30. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy. Paulick R; Caffier H Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852 [TBL] [Abstract][Full Text] [Related]
31. Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival. Eskelinen M; Lipponen P; Syrjänen K Anticancer Res; 1992; 12(1):91-5. PubMed ID: 1567186 [TBL] [Abstract][Full Text] [Related]
32. [CEA and TPA in cancer of the breast. Findings and criteria of use]. Torres Avisbal M; Ruíz de Almodovar Rivera JM; Villalba Moreno J; Olea Serrano N; Padilla Bolivar O; Pedraza Muriel V Rev Esp Oncol; 1985; 32(2):265-80. PubMed ID: 3843460 [TBL] [Abstract][Full Text] [Related]
33. [Distribution and prognostic value of CEA and TPA in cancer of the lung]. Leonardo E; Dogliotti C; Mancuso M; Sanfilippo B; Oliaro A Minerva Med; 1986 Mar; 77(11):375-9. PubMed ID: 3703330 [TBL] [Abstract][Full Text] [Related]
34. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients. Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626 [TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA]. Okamura Y; Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T Gan To Kagaku Ryoho; 1991 Jul; 18(8):1279-85. PubMed ID: 2069399 [TBL] [Abstract][Full Text] [Related]
36. [Estimates of circulating breast cancer-associated antigen CA 15-3 as a monitoring marker in patients with breast cancer]. Yoshimoto M; Akiyama F; Watanabe S; Kasumi F; Fukami A; Nakajima T; Nishi M; Kajitani T; Takahashi S Gan To Kagaku Ryoho; 1987 Jul; 14(7):2310-5. PubMed ID: 3475042 [TBL] [Abstract][Full Text] [Related]
37. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage]. Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935 [TBL] [Abstract][Full Text] [Related]
38. Clinical significance of statistical discrimination employing serum TA-4, TPA, and CEA levels in uterine cervical cancer. Yabushita H; Ogawa A; Masuda T; Noguchi M; Nakanishi M; Ishihara M Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1770-6. PubMed ID: 3782958 [TBL] [Abstract][Full Text] [Related]
39. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)]. Pompecki R; Schröder G; Garbrecht M; Frahm H Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696 [TBL] [Abstract][Full Text] [Related]
40. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer]. Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]